BCG, muramylpeptides, trained immunity (part II): a low molecular weight alternative to multicomponent bacterial immunostimulants for prevention of respiratory infections during a pandemic

During a pandemic, nonspecific immunoprophylaxis of SARS-CoV-2 infection and other acute respiratory infections (ARI), which can worsen the course of COVID-19, is increasingly in demand in addition to specific immunization. BCG vaccine appears to be one of the candidate immunostimulants in this rega...

Full description

Bibliographic Details
Main Authors: Oleg V. Kalyuzhin, Tatiana M. Andronova, Alexander V. Karaulov
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2021-01-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/61913/44950